Approvals/CIMA-AEMPS/OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA VISO FARMACEUTICA 20 MG/5 MG/12,5 COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA VISO FARMACEUTICA 20 MG/5 MG/12,5 COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Glenmark Arzneimittel Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 0d0599d6c252d967
Drug Cima Aemps Name: OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA VISO FARMACEUTICA 20 MG/5 MG/12,5 COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86101
Holder Company Name: Glenmark Arzneimittel Gmbh
Marketing Company Name: Glenmark Farmaceutica S.L.U
Holder Company Detail Path: /organization/glenmark-arzneimittel-gmbh
Authorization Date: 2021-07-26
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 20 mg/5 mg/12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glenmark Arzneimittel Gmbh
Company Detail Path: /organization/glenmark-arzneimittel-gmbh

OLMESARTAN MEDOXOMILO

20 mg

AMLODIPINO BESILATO

6,93 mg

HIDROCLOROTIAZIDA

12,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 26, 2021

Approval ID

0d0599d6c252d967

Type

Standard